Federico Stella

15PUBLICATIONS
134CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursMolecular targetsMedical mycologyChemotherapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Aug 10, 2026
Decade-long persistence of CD19 CAR T cells in B cell lymphomas.

|Jun 24, 2026
Ten-Year Outcomes after CAR T-Cell Therapy for B-Cell Lymphomas.

|May 15, 2026
Naïve CD4+ T-cells and disease status at CART infusion correlate with clinical outcomes in real-world large B-cell lymphoma patients receiving second-line CAR T therapy.

|May 05, 2026
Polatuzumab vedotin-containing regimens as bridge to CART: analysis from the CART-SIE study.

|Feb 06, 2026
The ancestral haplotype of P2RX5 yields a B-cell surface marker and a multi-lineage immunotherapy target.

Zhiwei Ang, Annette Castro, Luca Paruzzo

|Feb 04, 2026
Chimeric antigen receptor T cells against the IGHV4-34 B cell receptor specifically eliminate neoplastic and autoimmune B cells.

Ivan J Cohen, Audrey C Bochi-Layec, Jean Lemoine

Pageof 3

Frequent Collaborators

7 joint publications

Paolo Corradini

7 joint publications

Marco Ruella

6 joint publications

Luca Paruzzo

4 joint publications

Ilaria Cutini